Top 10 Pharma API Manufacturers in Mumbai
Mumbai has established itself as one of India’s largest pharmaceutical hubs, especially known for its high-quality API (Active Pharmaceutical Ingredients) manufacturers. The API market in Mumbai is an integral part of India’s overall pharmaceutical industry, valued at over USD 12 billion in 2024, with projections indicating continued growth driven by global demand and innovation.
Mumbai’s API sector plays a significant role in serving therapeutic fields such as cardiovascular, oncology, CNS, and anti-infectives.
In this article, we explore the top 10 pharma API manufacturers in Mumbai, leading the industry with advanced production capabilities, regulatory compliance, and a focus on quality.
Table of Contents
Mumbai’s API Market
Mumbai contributes a substantial share to the API manufacturing sector in India, with an annual growth rate projected to exceed 10%. This growth is supported by strategic factors, including advanced research facilities, a highly skilled labor force, and government support through policies and export incentives. By 2025, Mumbai’s API production capacity is expected to expand further, positioning the city as a global player in the pharmaceutical industry.
Why Choose API Manufacturers in Mumbai?
Mumbai’s pharmaceutical industry is a key contributor to India’s API market due to the following factors:
- Strategic Location: Proximity to ports enables efficient exports to global markets.
- Skilled Workforce: Mumbai’s educational institutions contribute skilled professionals to the API sector.
- Research & Development: Government incentives support R&D, allowing companies to focus on high-quality API production and innovation.
- Regulatory Compliance: Companies in Mumbai meet international standards such as WHO-GMP, USFDA, and EU-GMP, making them reliable API suppliers for global markets.
List of Top 10 API Manufacturing Companies in Mumbai
1. Wockhardt Ltd.
Wockhardt is a globally recognized pharmaceutical and biotechnology company dedicated to delivering high-quality, affordable medicines.
Known as one of India’s leading research-driven healthcare enterprises, Wockhardt has made significant advancements in pharmaceuticals, biotechnology, and operates a chain of advanced super specialty hospitals. With a diverse workforce of over 3,000 employees from 21 nationalities, Wockhardt is a truly global organization.
Headquartered in Mumbai, Wockhardt operates in the USA, UK, France, and other emerging markets. The company manages three research centers and twelve manufacturing plants focused on pharmaceutical and biopharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines.
At the heart of Wockhardt’s mission is innovation, utilizing science and technology to develop life-improving medicines. Driven by its strategic vision, “More & More with Less & Less,” Wockhardt continues to strive for breakthroughs that enhance patient health and deliver value to stakeholders worldwide.
Key Products:
- Adenosine
- Bethanechol Chloride
- Dextromethorphan Hbr
- Epinephrine
- Nadifloxacin
- Nicardipine HCL
- Pidotimod
- Sitagliptin Phosphate
Specialty: Anti-diabetic, nephrology, pain management, and anti-infective therapies
Certifications: US FDA, WHO-GMP, ISO
Contact them: Wockhardt Ltd., D-4 MIDC, Chikalthana, Chhatrapati Sambhajinagar, 431006, India
Website: www.wockhardt.com
2. Teva Pharmaceuticals & Chemical Industries India Pvt. Ltd.
Teva Pharmaceuticals & Chemical Industries India Pvt. Ltd. is part of Teva Pharmaceutical Industries, a leading global pharmaceutical company renowned as the largest manufacturer of generic drugs and one of the top 15 pharmaceutical companies worldwide.
Teva’s API division, Teva api, has a rich legacy dating back to 1935 with the founding of Assia, a company dedicated to producing veterinary and pharmaceutical ingredients. Over the years, Teva api has expanded its reach by acquiring and establishing top-tier manufacturing and development facilities across the globe, each aligned with the company’s rigorous standards for quality and innovation.
Today, Teva api operates 13 production facilities and six R&D centers worldwide, employing over 4,000 professionals across 14 international sites. Teva api offers the industry’s most extensive portfolio of more than 350 active pharmaceutical ingredients (APIs), making it a preferred global supplier. With a focus on advanced development, large-scale production capabilities, and exceptional customer support, Teva Pharmaceuticals & Chemical Industries India Pvt. Ltd. stands as an ideal partner for API needs.
Key Products:
- Abiraterone Acetate
- Allopurinol
- Bicalutamide
- Betamethasone Dipropionate
- Cabergoline
- Calcitriol
- Carboplatin
- Deferasirox
- Eletriptan HBr
- Eptifibatide
- Haloperidol
Specialty: Generics, cardiovascular, CNS, respiratory, and oncology APIs
Certifications: US FDA, WHO-GMP, ISO
Contact them: Office no. 8A, 8th floor, Tower C, Times Square Building, Andheri Kurla Road, Gamdevi, Marol, Andheri Mumbai- 400059, Maharashtra India
Website: www.teva-api.com
3. Unichem Laboratories Ltd.
Unichem Laboratories Ltd., founded by the visionary Late Mr. Amrut Mody, is among India’s most esteemed pharmaceutical companies, committed to enhancing health through superior-quality products. Headquartered in Mumbai, Unichem specializes in an array of therapeutic areas including gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives, and pain management.
With a team of over 3,100 dedicated professionals, Unichem operates six manufacturing facilities across India, each embodying the company’s high standards of quality and innovation.
Unichem’s API portfolio is a vital component of its strategic operations. The company’s facilities have earned accreditation from respected international regulatory bodies, including the US FDA, UK MHRA, ANVISA (Brazil), COFEPRIS (Mexico), PMDA (Japan), EUGMP, EDQM (Europe), WHO (Geneva), and TGA (Australia). With a focus on producing complex APIs, Unichem has filed 76 US Drug Master Files (DMFs) and 27 Certificates of Suitability (CEPs), underpinned by state-of-the-art manufacturing sites with a combined capacity of nearly 600 KL.
Key Products:
- Alfuzosin HCl
- Baclofen
- Chlorthalidone
- Donepezil HCl
- Guanfacine
- Hydrochlorothiazide
- Lamotrigine
- Metronidazole
- Phenylephrine HCl
- Ranolazine
- Tadalafil
- Zolpidem Tartrate
Specialty: Cardiovascular, gastroenterology, diabetology, and pain management APIs
Certifications: US FDA, WHO-GMP, ISO
Contact them: Unichem Laboratories Ltd., 47, Kandivli Industrial Estate, Kandivli (West), Mumbai – 400067, Maharashtra, India
Website: www.unichemlabs.com
4. Ultratech India Limited
Ultratech India Limited stands as a comprehensive pharmaceutical and life sciences company, specializing in the production of pharmaceutical finished dosage forms and Active Pharmaceutical Ingredients (APIs) while also providing cutting-edge drug discovery solutions. With a notable focus on pulmonary drug delivery systems, Ultratech manufactures a complete line of anti-asthmatic inhalation medications, including Dry Powder Inhalers (DPIs) and Pressurized Metered Dose Inhalers (pMDIs), targeting respiratory health needs.
In the API sector, Ultratech excels in developing and scaling new molecules through advanced and complex synthetic chemistry processes. The company also offers Custom Research and Manufacturing Services (CRAMS), including custom synthesis for new molecules, process development for bulk actives, and contract manufacturing services.
Its advanced manufacturing facilities support a broad range of bulk active drugs and intermediates across various therapeutic categories, providing flexibility for diverse product needs and market adaptability.
Key Products:
- Amlodipine Besilate IP/JP/BP/EP/USP
- Ezetimibe IP/USP
- Fluconazole IP/JP/BP/EP/USP
- Ketoconazole IP/JP/BP/EP/USP
- Bilastine
- Levocetirizine Hydrochloride BP I Di-HCl IP/USP
- Dolutegravir Sodium
- Valganciclovir HCl BP/EP/USP
- Fluticasone Propionate IP/BP/EP/USP
- Ipratropium Bromide IP/JP/BP/EP/USP
- Duloxetine HCl IP/BP/EP/USP
- Avanafil
Specialty: Pulmonary drug delivery systems, anti-asthmatic inhalation drugs, complex APIs
Certifications: US FDA, WHO-GMP, ISO
Contact them: Ultratech India Limited, 113, J.K. Chambers, Sector-17, Vashi, Navi Mumbai, India – 400 703
Website: https://www.ultratechindia.com/
5. Aarti Drugs Ltd
Aarti Drugs Ltd., established in 1984, is a prominent entity within the $900 million Aarti Group of Industries, specializing in the production of Active Pharmaceutical Ingredients (APIs), pharma intermediates, specialty chemicals, and formulations. Supported by a robust R&D division located at the Tarapur MIDC near its manufacturing sites, Aarti Drugs has evolved into a major player in the pharmaceutical industry, with an expansive product portfolio. Key APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, and Ofloxacin, while its specialty chemicals division produces products like Benzene Sulphonyl Chloride and Methyl Nicotinate.
With GMP-certified manufacturing units, Aarti Drugs is committed to quality and innovation. Its facilities in Tarapur, Maharashtra, and Sarigam, Gujarat, leverage over two decades of expertise to produce more than 50 bulk actives, intermediates, and specialty chemicals. Dedicated to becoming a trusted partner in the market, the company prioritizes product excellence, compliance, and timely delivery.
Key Products:
- Aceclofenac
- Diclofenac Sodium
- Ciprofloxacin HCL
- Metronidazole
- Ticlopidine HCL
- Fluconazole
- Niacin
- Benzenesulfonic acid
- Para chlorobenzenesulfonyl chloride
- Para Toluenesulfonamide
- 4-Sulfonamidophenylhydrazine. Hcl
- 1-(2,6-Dichlorophenyl)-2-indolinone
- 2-Methyl-5-Nitro lmidazole
Specialty: APIs, specialty chemicals, and formulations
Certifications: US FDA, WHO-GMP, ISO
Contact them: Aarti Drugs Ltd,Mahendra Industrial Estate, Ground Floor,
Road No 29, Plot No 109-D, SION (East), MUMBAI- 400 022.( INDIA)
Website: https://www.aartidrugs.co.in/
6. Lupin Limited
Lupin Limited, a global pharmaceutical leader, provides a broad range of branded and generic formulations, biosimilars, and active pharmaceutical ingredients (APIs). With over five decades of expertise, Lupin has established a strong presence in the US, India, Japan, and other key regions across APAC, EMEA, and LATAM. The company holds a prominent position in the Anti-Tuberculosis and Cephalosporin segments worldwide. Lupin’s focused therapeutic areas include women’s health in the US, neurology in Europe and Japan, and cardiac, diabetes, and respiratory care in India, along with ophthalmology and dermatology in LATAM.
Lupin operates 18 state-of-the-art manufacturing facilities in India, Japan, the US, Mexico, and Brazil, all benchmarked to international standards and regularly inspected for compliance by global regulatory authorities. With a dedicated workforce of 20,000 experts, Lupin drives significant research in new drug discovery and generics to meet evolving medical needs globally.
Key Products:
- Acebrophylline
- Aceclofenac IP
- Seratrodast
- Amisulpride BP
- Dulaglutide
- Aripiprazole
- Gatifloxacin
- Azithromycin
- Balofloxacin
- Bevacizumab
- Budesonide
Specialty: Branded formulations, generics, biosimilars, and APIs in areas such as anti-tuberculosis, cephalosporins, and women’s health
Certifications: US FDA, WHO-GMP, ISO
Contact them: Lupin Limited, 3rd Floor, Kalpataru Inspire, Off. Western Expressway Highway, Santacruz (East), Mumbai 400 055, India.
Website: https://www.lupin.com/
7. Chemino Pharma Ltd
Following the acquisition of Shakti Bioscience, Chemino Pharma expanded its product range, increased production capacity, and gained entry into new markets. Its state-of-the-art manufacturing facility in Vapi, Gujarat, meets rigorous standards and has earned approvals from prominent global clients.
Key Products:
- Citicoline Sodium
- Bupropion Hydrochloride
- Granisetron Hydrochloride
- Meloxicam
- Piroxicam
- Lidocaine Hydrochloride Monohydrate
- Lidocaine
- 2-bromo-3′-chloropropiophenone
Specialty: Generics, veterinary APIs, intermediates
Certifications: US FDA, WHO-GMP, ISO
Contact them: Chemino Pharma Ltd., 303, Western Edge 1,Western Express Highway, Magathane, Borivali (East), Mumbai – 400 066. Maharashtra,India.
Website: https://www.cheminopharma.com/
8. Mangalam Drugs & Organics Ltd
Mangalam Drugs & Organics Ltd., established in 1977, began manufacturing Active Pharmaceutical Ingredients (APIs) and intermediates at its facility in Vapi, Gujarat. With multi-product facilities across two locations and an in-house DSIR-certified Research & Development laboratory, Mangalam has built a strong reputation as a leading source for anti-malarial APIs. Over five decades, it has diversified its product portfolio to leverage operational synergies and economies of scale.
Recognized among Asia’s top companies in its product segments, Mangalam is also the world’s largest manufacturer for certain specialized APIs. The company’s manufacturing facilities are cGMP-compliant and meet both national and international quality standards, with advanced machinery ensuring high-quality production, streamlined processes, and stringent quality control at every step.
Key Products:
- Acyclovir (Aciclovir) [EP / IP / USP / Ph. Int.]
- Amodiaquine HCI (USP / IP / IH)
- Artemether (Ph.int. / IP)
- Artesunate [Ph. Int. / IP]
- Bisoprolol Fumarate [EP / USP]
- Chloroquine Phosphate (IP)
- Dihydroartemisinin (Ph.Int.)
- Dolutegravir Sodium [IH]
- 2-Dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol [DBA]
- 4,6-Dichloro-5-methoxy pyrimidine [DCMP]
- 4,7 Dichloroquinoline
- Ortho Phenoxy Methane Sulfonanilide
- Tenofovir Alafenamide Base
- Tenofovir Disoproxil Base
Specialty: Anti-malarial APIs, generics, intermediates
Certifications: US FDA, WHO-GMP, ISO
Contact them: Mangalam Drugs & Organics Limited Rupam Building, 3rd Floor, 239, P.D’ Mello Road, Near G.P.O., Mumbai – 400 001, Maharashtra, INDIA.
Website: https://www.mangalamdrugs.com/
9. Amoli Organics Pvt.Ltd.
Founded in 1992, Amoli Organics Pvt. Ltd. has established itself as a premier manufacturer of Active Pharmaceutical Ingredients (APIs) headquartered in Mumbai, India. With over three decades of collaboration with global healthcare leaders, Amoli’s expertise lies in advanced process chemistry, supported by EDQM and USFDA-approved facilities that serve the pharmaceutical sector worldwide.
Amoli offers an extensive range of APIs across therapeutic categories such as NSAIDs, antifungals, antidepressants, and hypolipidemics. The company’s state-of-the-art R&D center enables continuous product expansion into new therapeutic areas, ensuring it meets evolving industry demands. Backed by a team of over 1,100 dedicated professionals, Amoli has become a trusted name in India’s pharmaceutical landscape.
Amoli’s strategy focuses on continuous advancement in quality, regulatory compliance, and business innovation to maintain its position as a preferred and reliable API supplier globally.
Key Products:
- Aceclofenac BP / EP
- Apixaban
- Celecoxib BP / EP /USP
- Chlorthalidone EP /USP
- Deferasirox
- Diclofenac Diethylamine BP
- Dimethyl Fumarate
- Eslicarbazepine
- Mesalamine / Mesalazine
- Pirfenidone
- Solifenacin Succinate
- Ticagrelor
- Varenicline Tartarate
Specialty: NSAIDs, antifungal, antidepressant, hypolipidemic APIs
Certifications: US FDA, WHO-GMP, EDQM
Contact them: Amoli Organics Pvt.Ltd., 407, Dalamal House, Jamnalal Bajaj Road,Nariman Point, Mumbai – 400021
Website: https://www.amoliindia.com/
10. Keshava Organics Pvt. Ltd.
Keshava Organics Pvt. Ltd., headquartered in Mumbai, is a specialized manufacturer of antihistamine Active Pharmaceutical Ingredients (APIs) with a US FDA-approved facility. Located 100 km north of Mumbai, the facility undergoes regular audits and has achieved approval from numerous multinational companies that rely on its products. Since earning US FDA approval in September 2011, Keshava Organics has been recognized as a reliable supplier with a strong focus on quality and timely delivery.
As one of the API manufacturers in Mumbai with US FDA certification, Keshava Organics is known for its commitment to quality, adherence to EHS policies, and robust client satisfaction. The plant features advanced SS316, MS, and glass-lined reactors, along with separate areas dedicated to basic synthesis and API manufacturing. Designed in compliance with ICHQ7A guidelines, the facility upholds high standards across its operations.
Key Products:
- Pheniramine Maleate
- Chlorpheniramine Maleate
- Brompheniramine Maleate
- Dexchlorpheniramine Maleate
- Dexbrompheniramine Maleate
- Mepyramine Maleate
- Pyrilamine Maleate
- Chlorpheniramine Base
- Brompheniramine Base
- Mepyramine Base
- Pheniramine Base
Specialty: Antihistamine APIs
Certifications: US FDA, WHO-GMP
Contact them: Keshava Organics Pvt. Ltd., 321 Durian Estate, Goregaon Mulund Link Road, Goregaon East, Mumbai 400063 INDIA.
Website: https://www.keshavaindia.com/
Conclusion
Mumbai’s API manufacturing sector is a cornerstone of India’s pharmaceutical industry, offering a significant contribution to both domestic and international markets. As a prominent hub for API production, Mumbai houses key players such as Wockhardt, Lupin, and Teva API, each producing a wide range of active pharmaceutical ingredients across multiple therapeutic fields.
With over 150 production facilities in and around the city, Mumbai supports a substantial portion of India’s API exports, valued at around USD 5 billion in 2023, and plays a critical role in meeting global demand. Supported by advanced research facilities, a skilled workforce, and strategic government initiatives, the city’s API market is expected to continue its growth, catering to rising demands in oncology, cardiovascular, and diabetes treatments.
As Mumbai’s API industry expands, it not only fuels India’s pharmaceutical exports but also bolsters local employment, providing over 20,000 jobs across various sectors like R&D, quality assurance, and logistics. Investments exceeding USD 500 million have been directed towards modernizing facilities, enhancing regulatory compliance, and increasing production capacity, making Mumbai a central player in the API market.
For businesses and investors in the pharmaceutical sector, Mumbai offers a prime location with established infrastructure and direct access to global markets, making it a key driver in India’s journey toward self-reliance in pharmaceutical ingredients and a trusted supplier worldwide.
If you’re looking to partner with reliable pharma API manufacturers in Mumbai, consider the top companies listed here. Their commitment to quality, adherence to international standards, and diverse therapeutic specialties make them ideal for meeting pharmaceutical API needs. Visit their websites to learn more about their products and services, and connect for potential collaborations.
We write rarely, but only the best content.
